31P The IOpener study: Tyrosine kinase activity profiling to predict response to immune checkpoint inhibitors in patients with advanced stage non-small cell lung cancer

Bibliographic Details
Title: 31P The IOpener study: Tyrosine kinase activity profiling to predict response to immune checkpoint inhibitors in patients with advanced stage non-small cell lung cancer
Authors: Joode, K.D., Groen, H.J.M., van den Heuvel, M., Kloover, J.S., van der Meer, F., Stigt, J.A., van der Leest, C.H., Van Den Borne, B., de Wijn, R., Hurkmans, D.P., van den Heuvel, D.M.A., van Doorn, T., Pinedo, B., Kapiteijn, E., Debets, R., Verdegaal, E., van der Burg, S.H., Groten, J.P., Aerts, J.G., Mathijssen, R.H.
Source: In Immuno-Oncology and Technology December 2022 16 Supplement 1
Database: ScienceDirect
More Details
ISSN:25900188
DOI:10.1016/j.iotech.2022.100136
Published in:Immuno-Oncology and Technology
Language:English